Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study

Background: Elabela, a novel cardiac developmental peptide, has been shown to improve heart dysfunction. However, the roles and correlation of Elabela in predicting adverse cardiac events in hypertensive patients with heart failure (HF) remain largely unclear. Objective: To measure plasma levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zheng, Zhao, Lei, Martin, Sara, Zhang, Yeping, Dong, Ying, Zhong, Jiu-Chang, Yang, Xin-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960768/
https://www.ncbi.nlm.nih.gov/pubmed/33738301
http://dx.doi.org/10.3389/fcvm.2021.638468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960768/
https://www.ncbi.nlm.nih.gov/pubmed/33738301
http://dx.doi.org/10.3389/fcvm.2021.638468

Ejemplares similares